GB0705566D0 - Method of treating learning impairment in down's syndrome subjects - Google Patents

Method of treating learning impairment in down's syndrome subjects

Info

Publication number
GB0705566D0
GB0705566D0 GBGB0705566.8A GB0705566A GB0705566D0 GB 0705566 D0 GB0705566 D0 GB 0705566D0 GB 0705566 A GB0705566 A GB 0705566A GB 0705566 D0 GB0705566 D0 GB 0705566D0
Authority
GB
United Kingdom
Prior art keywords
learning impairment
syndrome subjects
treating learning
treating
subjects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0705566.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Dundee filed Critical University of Dundee
Priority to GBGB0705566.8A priority Critical patent/GB0705566D0/en
Publication of GB0705566D0 publication Critical patent/GB0705566D0/en
Priority to GB0805357A priority patent/GB2447791A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0705566.8A 2007-03-23 2007-03-23 Method of treating learning impairment in down's syndrome subjects Ceased GB0705566D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0705566.8A GB0705566D0 (en) 2007-03-23 2007-03-23 Method of treating learning impairment in down's syndrome subjects
GB0805357A GB2447791A (en) 2007-03-23 2008-03-25 Pharmaceutical formulations and compounds for use in alleviating conditions related to Down's syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0705566.8A GB0705566D0 (en) 2007-03-23 2007-03-23 Method of treating learning impairment in down's syndrome subjects

Publications (1)

Publication Number Publication Date
GB0705566D0 true GB0705566D0 (en) 2007-05-02

Family

ID=38024674

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0705566.8A Ceased GB0705566D0 (en) 2007-03-23 2007-03-23 Method of treating learning impairment in down's syndrome subjects
GB0805357A Withdrawn GB2447791A (en) 2007-03-23 2008-03-25 Pharmaceutical formulations and compounds for use in alleviating conditions related to Down's syndrome

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0805357A Withdrawn GB2447791A (en) 2007-03-23 2008-03-25 Pharmaceutical formulations and compounds for use in alleviating conditions related to Down's syndrome

Country Status (1)

Country Link
GB (2) GB0705566D0 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110742885A (en) * 2019-11-04 2020-02-04 五邑大学 Application of Harbin in preparation of lipid-lowering drugs

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013533239A (en) * 2010-06-25 2013-08-22 ファキュルテ ユニヴェルシテール ノートル−ダム ド ラ ペ Β-carboline derivatives useful for the treatment of proliferative diseases
WO2013026806A1 (en) * 2011-08-19 2013-02-28 Exonhit Sa Dyrk1 inhibitors and uses thereof
CN103145705B (en) * 2012-06-14 2016-04-06 南通大学 Beta-carboline alkaloid derivative, its preparation method and medicinal use thereof
US11547712B2 (en) 2017-11-20 2023-01-10 Icahn School Of Medicine At Mount Sinai Kinase inhibitor compounds and compositions and methods of use
US11788064B2 (en) 2018-01-05 2023-10-17 Icahn School Of Medicine At Mount Sinai Method of increasing proliferation of pancreatic beta cells, treatment method, and composition
CA3093340A1 (en) * 2018-03-20 2019-09-26 Icahn School Of Medicine At Mount Sinai Kinase inhibitor compounds and compositions and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19807993A1 (en) * 1998-02-26 1999-09-02 Bayer Ag Treating tumor necrosis factor mediated inflammatory disease, e.g. arteriosclerosis, using new or known beta-carboline derivatives
AU4919099A (en) * 1998-07-11 2000-02-01 University Of Bristol, The Compounds having activity at imidazoline receptors
EP1268477B1 (en) * 2000-03-15 2010-04-21 Sanofi-Aventis Deutschland GmbH Substituted beta-carbolines with ikb-kinase inhibiting activity
WO2005007672A2 (en) * 2003-06-20 2005-01-27 Coley Pharmaceutical Gmbh Small molecule toll-like receptor (tlr) antagonists
FR2869540B1 (en) * 2004-04-30 2008-05-16 Centre Nat Rech Scient Cnrse PHARMACEUTICAL COMPOSITIONS CONTAINING B-CARBOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110742885A (en) * 2019-11-04 2020-02-04 五邑大学 Application of Harbin in preparation of lipid-lowering drugs

Also Published As

Publication number Publication date
GB2447791A (en) 2008-09-24
GB0805357D0 (en) 2008-04-30

Similar Documents

Publication Publication Date Title
GB0624584D0 (en) Skin treatment apparatus and method
EP2091454A4 (en) Apparatus and method for skin treatment
TWI340735B (en) Water treatment method and water treatment apparatus
GB0620061D0 (en) Oesophageal treatment apparatus and method
EP2018235A4 (en) Surface treatment apparatus and method
EP2073739A4 (en) Vein treatment device and method
IL187444A0 (en) Tissue treatment device and method
BRPI0812585A2 (en) REDUCTION TREATMENT APPARATUS AND REDUCTION TREATMENT METHOD
EP2012687A4 (en) Improved spine fixation method and apparatus
IL215409A0 (en) Self-propellable endoscopic apparatus and method
EP1722804A4 (en) Skin treatment method with lactobacillus extract
GB0705617D0 (en) Bone treatment apparatus and method
EP2358261A4 (en) Pupillary assessment method and apparatus
GB0623005D0 (en) Fabric treatment method and composition
PL2073864T5 (en) Blood recuperation device and method
GB0805357D0 (en) Method of treating learning impairment in down's syndrome subjects
EP2172154A4 (en) Noninvasive biometric device and noninvasive biometric method
IL184441A0 (en) Method and device for water treatment
ZA200900489B (en) Apparatus and methods for skin treatment
EP2008610A4 (en) Treatment device and treatment method
GB0716030D0 (en) Method and apparatus for treating the skin
EP2343402A4 (en) Electrolytic treatment method and electrolytic treatment device
EP1922063A4 (en) Method of treating pain in patients
EP2328143A4 (en) Human voice distinguishing method and device
GB2466563B (en) Treatment apparatus and method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)